Our commercially savvy lawyers regularly lead strategic transactions and complex disputes for clients in a variety of industries and regions. We’ve included a small selection of matters for your convenience. Please feel free to contact experience@debevoise.com for a more complete list of matters in any particular category.

Debevoise Defeats Louisiana State’s Motion To Dismiss Reproductive Rights Case

Debevoise & Plimpton LLP and the Center for Reproductive Rights (CRR) recently defeated Louisiana’s motion to dismiss a comprehensive substantive due process challenge to the state’s TRAP laws. Last year, Debevoise and the CRR filed a lawsuit against the state of Louisiana’s abortion clinic licensing law that has since forced all but three clinics in the state to close. Read more >

Debevoise Advises The Carlyle Group on Its Strategic Minority Investment in DiscoverOrg

Debevoise & Plimpton LLP is advising The Carlyle Group on its strategic minority investment in DiscoverOrg, the leading global sales and marketing intelligence platform. Read more >

Debevoise Wins at New York High Court with Novel Legal Theories

Debevoise & Plimpton LLP secured an important win at the New York Court of Appeals on behalf of client Andrew Kolchins in his compensation dispute with his former employer. Debevoise also represents Mr. Kolchins and the brokerage firm he founded, Titan Energy Markets, in a related lawsuit commenced by EvoMarkets attempting to enforce restrictive covenants. Read more >

Debevoise Advises Ullico on the Cross-Border Take Private Acquisition of Student Transportation

Debevoise & Plimpton LLP is advising Ullico Inc. in the cross-border take private acquisition of Student Transportation Inc. (TSX:STB) (NASDAQ:STB) by a purchaser group sponsored by Ullico and Caisse de dépôt et placement du Québec (CDPQ). The transaction is expected to close by the end of the second quarter of 2018. Read more >

Debevoise Advises Motor Fuel Group in its £1.2 Billion Acquisition of MRH

Debevoise & Plimpton LLP has advised Motor Fuel Group (“MFG”) in the financing and tax structuring of its £1.2 billion acquisition of MRH, the U.K.'s largest petrol station and convenience retail operator. Read more >

Debevoise Advises J.P. Morgan Asset Management on Its Joint Venture Acquisition and Related Financing of Groupon Headquarters in $510 Million Landmark Deal

Debevoise & Plimpton LLP advised J.P. Morgan Asset Management on the $510 million acquisition and related financing of Groupon’s headquarters, located at 600 W. Chicago Avenue, Chicago, Illinois, in a joint venture with Sterling Bay. Read more >

Debevoise Advises MegaFon in the Discontinuation of Euroset Joint Venture

Debevoise & Plimpton LLP has advised PJSC MegaFon (“MegaFon”) in its transaction with PJSC VimpelCom (VimpelCom”), a Russian subsidiary of VEON Ltd. (“VEON”), to discontinue their Euroset joint venture. Read more >

Debevoise Advises Ambac on Completion of Its Segregated Account Rehabilitation and Holistic Restructuring Transaction

Debevoise & Plimpton LLP advised Ambac Financial Group, Inc. on its holistic restructuring transaction, including the successful conclusion of the rehabilitation of the Segregated Account of Ambac Assurance Corporation. Read more >

Debevoise Advises Johnson & Johnson on a Global Co-Development and Commercialization Agreement for TD-1473

Debevoise & Plimpton LLP is advising Johnson & Johnson on a global co-development and commercialization agreement between Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. Total consideration for the transaction is approximately $1 billion. Read more >

Debevoise Advises Syncora on Reinsurance Agreement with Assured Guaranty

Debevoise & Plimpton LLP is advising Syncora Holdings Ltd. on a reinsurance transaction with Assured Guaranty Corp., pursuant to which Assured will reinsure approximately $13.5 billion of Syncora insured financial guarantee policies, representing approximately 91% of Syncora's outstanding insured exposures. The transaction is expected to close no later than the end of the second quarter of 2018. Read more >

Debevoise Secures Victory for Allergan

Debevoise & Plimpton LLP secured a victory following almost nine years of litigation in the Celexa and Lexapro Marketing and Sales Practices multidistrict litigation (MDL). The United State District Court for the District of Massachusetts granted summary judgment in Allergan’s favor and dismissed all claims of the remaining plaintiffs. This avoids a jury trial that had been scheduled to begin March 12. Read more >